CYP2C9 and metabolic dysfunction-associated steatotic liver disease: The downregulation of CYP3A4 expression was also observed in HCV and ALD, but not in PSC and NAFLD, whereas CYP2C9 showed no significant changes in the abovementioned pathologies [8, 22].